These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 8635866

  • 1. Resistance to the chemosensitizer verapamil in a multi-drug-resistant (MDR) human multiple myeloma cell line.
    Abbaszadegan MR, Foley NE, Gleason-Guzman MC, Dalton WS.
    Int J Cancer; 1996 May 16; 66(4):506-14. PubMed ID: 8635866
    [Abstract] [Full Text] [Related]

  • 2. Evidence for cytoplasmic P-glycoprotein location associated with increased multidrug resistance and resistance to chemosensitizers.
    Abbaszadegan MR, Cress AE, Futscher BW, Bellamy WT, Dalton WS.
    Cancer Res; 1996 Dec 01; 56(23):5435-42. PubMed ID: 8968098
    [Abstract] [Full Text] [Related]

  • 3. Verapamil suppresses the emergence of P-glycoprotein-mediated multi-drug resistance.
    Futscher BW, Foley NE, Gleason-Guzman MC, Meltzer PS, Sullivan DM, Dalton WS.
    Int J Cancer; 1996 May 16; 66(4):520-5. PubMed ID: 8635868
    [Abstract] [Full Text] [Related]

  • 4. Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damage.
    Bellamy WT, Dalton WS, Kailey JM, Gleason MC, McCloskey TM, Dorr RT, Alberts DS.
    Cancer Res; 1988 Nov 15; 48(22):6365-70. PubMed ID: 3180056
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers.
    Chen YL, Yang TY, Chen KC, Wu CL, Hsu SL, Hsueh CM.
    Cell Oncol (Dordr); 2016 Oct 15; 39(5):411-433. PubMed ID: 27306525
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
    Sulová Z, Macejová D, Seres M, Sedlák J, Brtko J, Breier A.
    Toxicol In Vitro; 2008 Feb 15; 22(1):96-105. PubMed ID: 17920233
    [Abstract] [Full Text] [Related]

  • 14. [MDR (Multiple Drug Resistant) type of resistance to chemotherapy in clinical practice].
    Oudard S, Marie JP, Pujade Lauraine E.
    Bull Cancer; 1996 Aug 15; 83(8):609-18. PubMed ID: 8869040
    [Abstract] [Full Text] [Related]

  • 15. Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability.
    Drori S, Eytan GD, Assaraf YG.
    Eur J Biochem; 1995 Mar 15; 228(3):1020-9. PubMed ID: 7737146
    [Abstract] [Full Text] [Related]

  • 16. A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier.
    Hendrikse NH, de Vries EG, Eriks-Fluks L, van der Graaf WT, Hospers GA, Willemsen AT, Vaalburg W, Franssen EJ.
    Cancer Res; 1999 May 15; 59(10):2411-6. PubMed ID: 10344751
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL, Onda K, Tanaka S, Toma T, Hirano T, Oka K.
    Cancer Chemother Pharmacol; 2002 May 15; 49(5):391-7. PubMed ID: 11976833
    [Abstract] [Full Text] [Related]

  • 19. Effect of Stemona curtisii root extract on P-glycoprotein and MRP-1 function in multidrug-resistant cancer cells.
    Limtrakul P, Siwanon S, Yodkeeree S, Duangrat C.
    Phytomedicine; 2007 Jun 15; 14(6):381-9. PubMed ID: 17467965
    [Abstract] [Full Text] [Related]

  • 20. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
    Theyer G, Schirmböck M, Thalhammer T, Sherwood ER, Baumgartner G, Hamilton G.
    J Urol; 1993 Nov 15; 150(5 Pt 1):1544-7. PubMed ID: 8105110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.